Simon J. Johnston

1.1k total citations
29 papers, 592 citations indexed

About

Simon J. Johnston is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Simon J. Johnston has authored 29 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Oncology and 12 papers in Genetics. Recurrent topics in Simon J. Johnston's work include Breast Cancer Treatment Studies (13 papers), Estrogen and related hormone effects (12 papers) and Advanced Breast Cancer Therapies (6 papers). Simon J. Johnston is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Estrogen and related hormone effects (12 papers) and Advanced Breast Cancer Therapies (6 papers). Simon J. Johnston collaborates with scholars based in United Kingdom, United States and Japan. Simon J. Johnston's co-authors include Kwok‐Leung Cheung, Ian O. Ellis, Jason S. Carroll, Andrew R. Green, David Dodwell, Andrew Wardley, Pippa Corrie, Gemma Clarke, Binafsha Manzoor Syed and Isla Kuhn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Simon J. Johnston

26 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon J. Johnston United Kingdom 14 286 214 182 106 91 29 592
Jinli Wei China 12 118 0.4× 209 1.0× 269 1.5× 71 0.7× 43 0.5× 25 559
Johannes Huelsenbeck Germany 16 212 0.7× 95 0.4× 310 1.7× 96 0.9× 51 0.6× 20 893
Juliana Giacomazzi Brazil 17 396 1.4× 215 1.0× 278 1.5× 84 0.8× 195 2.1× 43 827
Dario R. Roque United States 13 140 0.5× 193 0.9× 242 1.3× 42 0.4× 39 0.4× 37 654
Mamoru Shimada Japan 10 135 0.5× 94 0.4× 217 1.2× 49 0.5× 41 0.5× 14 525
Judit Kocsis Hungary 15 310 1.1× 76 0.4× 298 1.6× 73 0.7× 22 0.2× 26 711
Hongbing Cai China 21 332 1.2× 386 1.8× 616 3.4× 105 1.0× 30 0.3× 66 1.2k
Monique Albert Canada 15 87 0.3× 174 0.8× 320 1.8× 78 0.7× 81 0.9× 22 632
Kelly Coffey United Kingdom 13 123 0.4× 102 0.5× 494 2.7× 212 2.0× 89 1.0× 25 762
Ronald J. Whitley United States 8 93 0.3× 129 0.6× 182 1.0× 30 0.3× 50 0.5× 13 483

Countries citing papers authored by Simon J. Johnston

Since Specialization
Citations

This map shows the geographic impact of Simon J. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon J. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon J. Johnston more than expected).

Fields of papers citing papers by Simon J. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon J. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon J. Johnston. The network helps show where Simon J. Johnston may publish in the future.

Co-authorship network of co-authors of Simon J. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Simon J. Johnston. A scholar is included among the top collaborators of Simon J. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon J. Johnston. Simon J. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamilton, Erika, S. Loibl, Thomas Bachelot, et al.. (2025). CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2– early breast cancer. Future Oncology. 21(7). 795–806. 1 indexed citations
2.
3.
4.
Johnston, Simon J., Binafsha Manzoor Syed, Ruth Parks, et al.. (2020). Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age. Cancers. 12(3). 712–712. 4 indexed citations
5.
Parks, Ruth, et al.. (2019). Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy. SHILAP Revista de lepidopterología. 8(1). 1–11. 36 indexed citations
6.
Kurozumi, Sasagu, Chitra Joseph, Mansour Alsaleem, et al.. (2019). Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer. Breast Cancer Research and Treatment. 176(1). 63–73. 12 indexed citations
7.
Johnston, Simon J., Mohammed A. Aleskandarany, Sasagu Kurozumi, et al.. (2018). Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair. BMC Cancer. 18(1). 1027–1027. 1 indexed citations
8.
Johnston, Simon J. & Kwok‐Leung Cheung. (2018). Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation. Oncology and Therapy. 6(2). 141–156. 28 indexed citations
9.
Joseph, Chitra, Maryam Althobiti, Islam M. Miligy, et al.. (2018). Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer. Breast Cancer Research and Treatment. 174(2). 387–399. 49 indexed citations
10.
Kurozumi, Sasagu, Chitra Joseph, Mohammed A. Aleskandarany, et al.. (2018). Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer. Breast Cancer Research and Treatment. 172(1). 61–68. 11 indexed citations
11.
Alfarsi, Lutfi, Simon J. Johnston, Dong‐Xu Liu, Emad A. Rakha, & Andrew R. Green. (2018). Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer. Histopathology. 73(4). 545–558. 15 indexed citations
12.
Johnston, Simon J. & Jason S. Carroll. (2015). Transcription factors and chromatin proteins as therapeutic targets in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1855(2). 183–192. 30 indexed citations
13.
Clarke, Gemma, Simon J. Johnston, Pippa Corrie, Isla Kuhn, & Stephen Barclay. (2015). Withdrawal of anticancer therapy in advanced disease: a systematic literature review. BMC Cancer. 15(1). 892–892. 54 indexed citations
14.
Johnston, Simon J. & Kwok‐Leung Cheung. (2015). The Role of Primary Endocrine Therapy in Older Women with Operable Breast Cancer. Future Oncology. 11(10). 1555–1565. 11 indexed citations
15.
Johnston, Simon J., Ian Thomas, Carys Jones, et al.. (2012). Comparison of bacterial identification by MALDI-TOF mass spectrometry and conventional diagnostic microbiology methods: agreement, speed and cost implications. British Journal of Biomedical Science. 69(2). 47–55. 47 indexed citations
16.
17.
Syed, Binafsha Manzoor, Simon J. Johnston, Andrew R. Green, et al.. (2011). Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic. Annals of Oncology. 23(6). 1465–1471. 24 indexed citations
18.
Syed, Binafsha Manzoor, Waleed Al‐Khyatt, Simon J. Johnston, et al.. (2011). Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre. British Journal of Cancer. 104(9). 1393–1400. 36 indexed citations
19.
Johnston, Simon J. & Kwok‐Leung Cheung. (2010). Fulvestrant - A Novel Endocrine Therapy for Breast Cancer. Current Medicinal Chemistry. 17(10). 902–914. 63 indexed citations
20.
Dodwell, David, Andrew Wardley, & Simon J. Johnston. (2006). Postmenopausal advanced breast cancer: Options for therapy after tamoxifen and aromatase inhibitors. The Breast. 15(5). 584–594. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinli Wei Breakdown of academic impact, for papers by Johannes Huelsenbeck Breakdown of academic impact, for papers by Juliana Giacomazzi Breakdown of academic impact, for papers by Dario R. Roque Breakdown of academic impact, for papers by Mamoru Shimada Breakdown of academic impact, for papers by Judit Kocsis Breakdown of academic impact, for papers by Hongbing Cai Breakdown of academic impact, for papers by Monique Albert Breakdown of academic impact, for papers by Kelly Coffey Breakdown of academic impact, for papers by Ronald J. Whitley
Rankless by CCL
2026